Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests

2007 ◽  
Vol 38 (3) ◽  
pp. 204-209 ◽  
Author(s):  
Annedore Tischer ◽  
Markus Gassner ◽  
Jean-Luc Richard ◽  
Franziska Suter-Riniker ◽  
Annette Mankertz ◽  
...  
2006 ◽  
Vol 44 (8) ◽  
pp. 2733-2738 ◽  
Author(s):  
M. H. Arguelles ◽  
M. L. Orellana ◽  
A. A. Castello ◽  
G. A. Villegas ◽  
M. Masini ◽  
...  

1991 ◽  
Vol 33 (3) ◽  
pp. 199-204 ◽  
Author(s):  
Linda W-L. Chui ◽  
Raymond G. Marusyk ◽  
Henry F. Pabst

Vaccine ◽  
2004 ◽  
Vol 22 (3-4) ◽  
pp. 544
Author(s):  
Susan van den Hof ◽  
Arianne B van Gageldonk-Lafeber ◽  
Robert S van Binnendijk ◽  
Pieter G.M van Gageldonk ◽  
Guy A.M Berbers

2005 ◽  
Vol 134 (1) ◽  
pp. 79-85 ◽  
Author(s):  
S. A. IBRAHIM ◽  
A. ABDALLAH ◽  
E. A. SALEH ◽  
A. D. M. E. OSTERHAUS ◽  
R. L. DE SWART

SUMMARYWe conducted a prospective birth cohort study in rural Sudan to assess measles virus (MV)-specific antibody levels at different time points in infancy. Dried blood spots were collected on filter paper at birth (cord blood) and at ages 6, 12 and 24 months (heel-prick). Maternally derived MV-specific antibody levels were high in cord blood samples, but at the age of 6 months had dropped below cut-off values in half of the infants. By extrapolation it was concluded that the current Expanded Programme of Immunization (EPI) target age for measles vaccination of 9 months was an appropriate choice for this area. At the age of 24 months acquired MV-specific antibodies were detected in 65–85% of the cohort, which corresponded well with the 79% of infants reported to be vaccinated by this age. This study demonstrates the usefulness of filter paper blood samples for seroepidemiological studies in developing countries.


Author(s):  
Michael J Peluso ◽  
Sadie E Munter ◽  
Kara L Lynch ◽  
Cassandra Yun ◽  
Leonel Torres ◽  
...  

Abstract We report a patient with connective tissue disease who developed modest SARS-CoV-2 receptor binding domain-specific antibody levels and a lack of neutralization capacity, despite having received three mRNA COVID-19 vaccines and holding anti-B cell therapy for >7 months prior to vaccination. The patient developed virus-specific T cell responses.


AIDS ◽  
2007 ◽  
Vol 21 (12) ◽  
pp. 1664-1666 ◽  
Author(s):  
Olivier Gasser ◽  
Marcel Wolbers ◽  
Ingrid Steffen ◽  
Hans H Hirsch ◽  
Manuel Battegay ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document